Seeking Alpha

Cepheid (CPHD)

()

News & PR
Market Currents

Buzz
Twitter: CPHD

Business Intelligence
Transcripts
Events
Key Developments

Analysis - Latest Articles by most recent | most commented

Cepheid Narrows Loss in Q3

Nov 30 • Zacks.com • Comment!
Comparing Medicine’s Cost and Effectiveness

Jul 1 • Eric Savitz • 6 Comments
19 'Bathwater Babies' and 20 'Dogs with Fleas' Stocks for the Week

Mar 22 • J Clinton Hill • 2 Comments
Create Your Own Diagnostics ETF

Jan 21 • Mike Havrilla • 3 Comments
Hedge Fund Tracking: Farallon Capital Management (Thomas Steyer), Q3 2008

Jan 6 • Market Folly • 2 Comments
Best and Worst Performing Stocks on Earnings

Aug 19, 2008 • Bespoke Investment Group • 2 Comments
Be Selective with Medical Device Companies

Aug 6, 2008 • Zacks.com • 1 Comment
Cepheid: Stock Plunge Presents Buy Opportunity

Jul 29, 2008 • Douglas Cress • Comment!
Second Quarter Earnings Season: Biggest Winners and Losers

Jul 27, 2008 • Bespoke Investment Group • Comment!
Bernanke, the Greatest Speculator - Fast Money (6/25/08)

Jun 26, 2008 • SA Editor Miriam Metzinger • Comment!
Cepheid Takes Hit on False MRSA Testing Claim

Mar 12, 2008 • Michael Shulman • Comment!
Last Year's Best Stocks Have Been This Year's Worst

Mar 2, 2008 • Bespoke Investment Group • 2 Comments
Tuesday's Options Report: XLF, AIG, ALB, THRX, SGP, CPHD, IGT, PDE

Feb 12, 2008 • Andrew Wilkinson • Comment!
2007's Best, Worst Performers Faring Poorly in 2008

Jan 16, 2008 • Bespoke Investment Group • Comment!
Cepheid: Is the MRSA Infection an Investment Opportunity?

Jan 2, 2008 • Michael Shulman • 1 Comment
Can Cepheid Power Past $25?

Dec 19, 2007 • Marlowe Cassetti • Comment!
Time to Buy Molecular Diagnostics Company Cepheid

Dec 4, 2007 • Michael Michaud • 1 Comment
Four Molecular Diagnostics Companies With An Edge

Jun 20, 2007 • Sara Calabro • 1 Comment
FDA Approves Cepheid’s Test For Infectious Bacteria

Apr 23, 2007 • Sara Calabro • Comment!
Neurochem Announcement Lowers Alzhemed Expectations - Barron's

Apr 22, 2007 • SA Editor Judy Weil • Comment!
Cepheid's Buyout Attractions are Overrated - Barron's

Apr 15, 2007 • SA Editor Judy Weil • Comment!
Veteran's Administration Contractors: A Good Investment - Barron's

Mar 25, 2007 • SA Editor Judy Weil • Comment!
Biotech Day in Review: FluMist from MedImmune Outperforms Injected Vaccine

Feb 16, 2007 • Centient Biotech Investor • Comment!
Biotech Stocks Day-in-Review: Lilly Drug Effective In Pancreatic Cancer

Jan 18, 2007 • Centient Biotech Investor • Comment!

Cepheid (CPHD)

Analysis - Latest Articles by most recent | most commented

The Seeking Alpha 100

Fastest Climbers

Top Commenters

Top Instabloggers

Top StockTalkers